Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma

NCT07235007 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Extrahepatic Cholangiocarcinoma

Interventions

DEVICE: Endobiliary Radiofrequency Ablation (EB-RFA)
DEVICE: Plastic Biliary Stent

Sponsor

Aichi Medical University